Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship

doi:10.4330/wjc.v15.i5.229

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5335)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

466

WORD

HTML

3486

Figures (1-5)

325

Tables (1-2)

303

Sum=4618

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

199

Download

518

Sum=717

May 26, 2023 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Cardiol. May 26, 2023; 15(5): 229-243
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.229

Full Size Figure Download Figure

Figure 1 Interplay of various common risk factors in the pathogenesis of coronary artery disease and atrial fibrillation. Variable genetic expression manifests as varied clinical phenotype in the form of either or both atrial fibrillation and coronary artery disease in an individual. AF: Atrial fibrillation; CAD: Coronary artery disease; EAD: Early after depolarization; DAD: Delayed after depolarization; HSPs: Heat shock proteins; IL: Interleukin; MPO: Myeloperoxidase; NO: Nitric oxide; PGs: Prostaglandins; ROS: Reactive oxygen species; TGF-β: Transforming growth factor beta.

Citation: Batta A, Hatwal J, Batta A, Verma S, Sharma YP. Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship. World J Cardiol 2023; 15(5): 229-243
URL: https://www.wjgnet.com/1949-8462/full/v15/i5/229.htm
DOI: https://dx.doi.org/10.4330/wjc.v15.i5.229